Korean Journal of Radiology · 2007 · 23 citations · 29 references
MedicineOncologyPharmacologyCancer PharmacologyInterventional RadiologyTumor PathologyInterventional OncologyRabbit OncologyHepatic Tumor ImagingHepatic TumorsLiver Tumor TherapyTherapeutic Efficacy AssessmentTumor Growth ModelingTumor Growth MonitoringTumor Uptake KineticsTumor Volume Measurement
OBJECTIVE: We wanted to investigate the feasibility of using FDG-PET for evaluating the antitumor effect of intraarterial administration of a hexokinase II inhibitor, 3-bromopyruvate (3-BrPA), in a rabbit VX2 liver tumor model. MATERIALS AND METHODS: VX2 carcinoma was grown in the livers of ten rabbits. Two weeks later, liver CT was performed to confirm appropriate tumor growth for the experiment. After tumor volume-matched grouping of the rabbits, transcatheter intraarterial administration of 3-BrPA was performed (1 mM and 5 mM in five animals each, respectively). FDG-PET scan was performed the day before, immediately after and a week after 3-BrPA administration. FDG uptake was semiquantified by measuring the standardized uptake value (SUV). A week after treatment, the experimental animals were sacrificed and the necrosis rates of the tumors were calculated based on the histopathology. RESULTS: The SUV of the VX2 tumors before treatment (3.87+/-1.51 [mean+/-SD]) was significantly higher than that of nontumorous liver parenchyma (1.72+/-0.34) (p < 0.0001, Mann-Whitney U test). The SUV was significantly decreased immediately after 3-BrPA administration (2.05+/-1.21) (p = 0.002, Wilcoxon signed rank test). On the one-week follow up PET scan, the FDG uptake remained significantly lower (SUV 1.41+/-0.73) than that before treatment (p = 0.002), although three out of ten animals showed a slightly increasing tendency for the FDG uptake. The tumor necrosis rate ranged from 50.00% to 99.90% (85.48%+/-15.87). There was no significant correlation between the SUV or the SUV decrease rate and the tumor necrosis rate in that range. CONCLUSION: Even though FDG-PET cannot exactly reflect the tumor necrosis rate, FDG-PET is a useful modality for the early assessment of the antitumor effect of intraarterial administration of 3-BrPA in VX2 liver tumor.
29
Kunio Okuda, Toshio Ohtsuki, Hiroshi Obata et al. · Cancer · 1985 · 1.9K citations · Full text
Hepatic artery embolization in 120 patients with unresectable hepatoma.
R Yamada, Morio Sato, M Kawabata et al. · Radiology · 1983 · 992 citations
The applications of PET in clinical oncology.
Ludwig G. Strauss, Peter S. Conti · PubMed · 1991 · 855 citations
Medicine, Nuclear Medicine, Oncology +17
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
P. Som, Harold Atkins, D. Bandoypadhyay et al. · Journal of Computer Assisted Tomography · 1980 · 503 citations